Tumor-Stroma interactions in pancreatic cancer: Will this sparc prove a raging fire?

Cancer Biology and Therapy

Volumn 7, Issue 11, 2008, Pages 1817-1818

  Edmonds, Christine ^a   Cengel, Keith A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Desmoplastic; Fibrosis; Pancreatic cancer; Prognosis; Radiation; SPARC; Survival

Indexed keywords

OSTEONECTIN; RECOMBINANT PROTEIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL INTERACTION; HUMAN; NOTE; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STELLATE CELL; STROMA CELL; TUMOR CELL; ANOXIA; CHEMISTRY; COCULTURE; CYTOSKELETON; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NECROSIS; NEOPLASM; PANCREAS TUMOR; PATHOLOGY; TIME; TUMOR CELL LINE;

ANOXIA; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOSKELETON; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; NECROSIS; NEOPLASMS; OSTEONECTIN; PANCREATIC NEOPLASMS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 77958184469     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Shimosegawa T. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 2008; 295: 709-17.
2. Bachmen MG, Schneider E, Gross H, Weidenbach H, Schmidt RM, Menke A, Siech M, Berger H, Grunert A, Adler G. Identification, culture and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115:421-32.
3. Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E, Llera AS. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 2008; 27:691-705.
4. Ledda M F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OL. The expression on the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 1997;108:210-4.
5. Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, Schmitt R, Bosserhoff A, Vogt T. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol 2003; 12:761-71.
6. Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 1999; 30: 339-44.
7. Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot and Essenti Fatty Acids 2005; 72:267-72.
8. Golembieski WA, Ge S, Nelson K, Mikkelsen T, Rempel SA. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci 1999; 17:463-72.
9. Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL, Sage EH. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res 2003; 63:5376-80.
10. Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 2007; 25:319-25.
11. Mantoni TS, Schendel RRE, Rodel F, Niedobitek G, Al-Assar O, Masamune A, Brunner TB. Stromal SPARC expression and patient survival afer chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Bio Ther 2008; 7: XXX-XXX.
12. Puolakkainen PA, Brekken RA, Muneer S, Sage EH. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. ol Cancer Res 2004; 2:215-24.
13. Arnold S, Mira E, Muneer S, Korpanty G, Beck AW, Holloway SE, Manes S, Brekken RA. orced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the abscence of host SPARC. xp biol med 2008; 233:860-73.